Posted On: 03/12/2016 12:04:47 PM
Post# of 30066
Hey RS,
Nice breakdown!
Small typo - two Phase III 's being planned.
As you put it in your post #22755
http://investorshangout.com/post/view?id=3607901
Cheers
Nice breakdown!
Quote:
Now add cGMP to that list, a Phase II beginning and two Phase II being planned.
Small typo - two Phase III 's being planned.
As you put it in your post #22755
Quote:
The phase 2 is for adult burns with the Doc. They are planning two phase 3's
Amarantus is planning three distinct clinical development programs for ESS, all of which have the opportunity to gain rapid market approval in various orphan dermatologic conditions:
1- Adult severe burns: Initiating a 10-patient Phase II clinical development program with US Army study under CRADA at ISR and two additional leading civilian burn center
2- Pediatric severe burns: Evaluating Phase III development program designs with leading pediatric burn center(s) in the United State
3- Giant Congenital Melanocytic Nevi (GCMN): Evaluating pivotal Phase III development program designs with leading dermatology center(s) in the United States
http://investorshangout.com/post/view?id=3607901
Cheers
(6)
(1)
